US Food and Drug Administration
US Food and Drug Administration
Pelacarsen reduced lipoprotein(a) (Lp(a)) by 78% in a Phase III trial of more than 8,300 adults yet produced no reduction in major adverse cardiovascular events, raising questions about whether lowering …
An international trial of 702 randomized adults found left bundle branch pacing (LBBP) lowered the hazard of death, heart failure hospitalization or pacing-induced cardiomyopathy by 59% (hazard ratio 0.41) versus …
Measles infections in the United States and Mexico have already exceeded all of 2025, with Pennsylvania recording five deaths and more than 1,000 infections as vaccine exemptions reach an all-time …
A matched cohort of 52,330 women aged 45 to 59 found no excess risk of heart attack, stroke, blood clots, or death over 12 years — with no meaningful difference …
Phase III SAFFRON data show osimertinib plus savolitinib cut progression or death risk by 45% and death risk by 32% versus chemotherapy in MET-driven epidermal growth factor receptor-mutated non-small cell …
Phase III DeLLphi-305 data show tarlatamab plus durvalumab extended median overall survival to 21.1 months versus 12.7 months with durvalumab alone in extensive-stage small cell lung cancer maintenance.
Johnson & Johnson’s oral RIPTAC molecule JNJ-6143 cut prostate-specific antigen (PSA) levels by at least half in 77% of evaluable patients at 50 mg in phase 1 data presented at …
On October 14, 2026, the FDA announced the Rare Disease Framework Initiative to develop a fit-for-purpose framework for rare disease drug development, led by its Rare Disease Innovation Hub, with …
The FDA on October 14 expanded Anktiva (nogapendekin alfa inbakicept-pmln) to adults with BCG-unresponsive, high-grade papillary-only non-muscle-invasive bladder cancer, as ImmunityBio works through a March warning letter over its promotion …
The FDA approved GSK and Ionis’s bepirovirsen for a narrow group of adults with chronic hepatitis B; 19% of treated trial patients still had the virus controlled, with hepatitis B …
You must be logged in to post a comment.